ArticleFrontiers in oncology2022

SHMT2 regulates serine metabolism to promote the progression and immunosuppression of papillary renal cell carcinoma.

Weiyu Kong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.